Cancer Supportive Care: Oral Palonosetron Approved in EU

The Second Generation 5-HT3 Receptor Antagonist Palonosetron, Already Approved as an Intravenous Solution Formulation in More Than 60 Countries Worldwide Including US, EU and Japan, Obtains the European Marketing Authorization for 0.5 mg Oral Capsules

LUGANO, Switzerland, May 10, 2010 – Palonosetron 0.5 mg soft gelatine capsule oral formulation has been
approved by the EMA (European [...]

Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.

Global Acquisition Expands Ferring's Role in Women's Health
SAINT-PREX, Switzerland, May 10, 2010 – Ferring Pharmaceuticals today announced an agreement that will expand its
Women's Health product portfolio with the acquisition of the global rights to
Xanodyne Pharmaceutical's LYSTEDA(TM) (tranexamic acid), a first-in-class,
non-hormonal therapy indicated specifically for treatment of women with
cyclic heavy menstrual bleeding (HMB). The company [...]

Health Robotics’ i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances

BOZEN, SUD-TIROL, Italy, May 10, 2010 – Health Robotics today announced i.v.STATION's certification achieving
compliance with a host of global security guidelines for controlled
substances, including tamper-evident syringe caps, biometric identification,
restricting nursing access only to ready-to-administer IVs, single-dose
storage and retrieval, etc.

"In addition to being the only company in the world proven to [...]

Lizann Prosser, Former Deloitte Director, Named New President of Crown Agents USA, Inc.

WASHINGTON, May 10, 2010 – Crown Agents USA, Inc. (CA-USA) is pleased to announce that Lizann
Prosser, former senior manager of Deloitte's Health and Social Protection
Practice, has been chosen as president of Crown Agents USA. She assumed her
new post in April 2010 becoming the CA-USA president and chief executive
officer.

Ms. Prosser is [...]

Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, May 10, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties of the EP-2104R MRI imaging agent, which
will be auctioned on May 28, 2010, include potential revenue sharing from the
first commercial sale of non-MRI imaging [...]

Gates Foundation Funds 78 New Innovative Global Health Projects Including Cell Phone Blood Tests, Carnivorous Plants and Sweat-Triggered Vaccines

Grants From 18 Countries Poised to Help Prevent and Diagnose Infectious Disease and Promote Family Health

LONDON, May 11, 2010 – The Bill & Melinda Gates Foundation today announced 78 grants of
US$100,000 each in the latest round of Grand Challenges Explorations. Grants
include the development of a low-cost cell phone microscope to diagnose
malaria, study of the [...]

PharmaTelevision Partners With Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

OXFORD, England, May 12, 2010 – PharmaTelevision(R) announced that as of today the groundbreaking online
TV channel for the BioPharma industry, is teaming up with Reuters Insider, a
new interactive on-demand video platform designed to change the way financial
professionals consume and distribute news, research and information.

"Today's generation of financial professionals access and [...]

Activity-Based Payments and Pay-for-Performance Initiatives Step up the Need for Effective Business Analytics Solutions in the European Healthcare Sector, Finds Frost & Sullivan

LONDON, May 12, 2010 – Business analytics solutions are considered the face of business
intelligence (BI) for healthcare providers, as they assist healthcare
managers and hospital management to compile, arrange and manage clinical,
financial and administrative data in a defined protocol, thereby facilitating
informed business decisions. The European healthcare sector has mostly
adopted activity-based payments. The current trend is [...]

Algorithme Pharma Announces a Strategic Appointment

LAVAL, Canada, May 12, 2010 – Doug Peel, Executive Chairman of the Board of Directors of Algorithme
Pharma, is pleased to announce the appointment of Christopher Perkin as the
company's President and Chief Executive Officer. Mr. Perkin will officially
join the company on May 31st.

This important appointment confirms Algorithme Pharma's commitment to
the development [...]

Bounty.Com Parents Poll Reveals Baby Name Regrets

LONDON, May 11, 2010 – According to a study by www.bounty.com, one in five
parents REGRET the names they have chosen for their children and 19 per cent
of folk are fed up with the sheer number of other children sharing the same
moniker.

In hindsight mums and dads claim they wouldn't have chosen
names [...]

Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division

Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets; holds option for more than 40 additional products

ABBOTT PARK, Illinois, May 11, 2010 – Further strengthening its global competitive position, Abbott (NYSE: ABT)
today announced a licensing and supply agreement with Zydus Cadila of India
for a portfolio of pharmaceutical products that Abbott will commercialize [...]

‘Depression’ is Newest Disability Intensive Course Introduced to College of Direct Support Curriculum

ATLANTA, Georgia, May 11, 2010 – The College of Direct Support (CDS), an internet-based college
for Direct Support Professionals (DSPs) and managed in partnership by
Elsevier I MC Strategies and the University of Minnesota's Research and
Training Center, has introduced its newest Disability Intensive Course (DIC)
into the CDS Curriculum – "Depression."

The course on [...]

IVT Will Demo the World’s First 3G based mHealth Solution for Three Major Chronic Diseases at ATA and INDO MEDICA

BEIJING, May 11, 2010 – IVT today announced that it has completed a major update on its Mobile
Health solution (www.mhealthservice.com/ ) and will demo the first
three 3G systems based Mobile Health solutions for three major chronic
diseases (hypertension, heart diseases and diabetes) at the coming ATA 2010
and INDO MEDICA in May. This update includes the [...]

Can Resveratrol Make You Smarter?

LONDON, May 11, 2010 – The subject of extensive studies across the world, Resveratrol is proving
to be a major talking point in the scientific community. And as evidence
comes to light of the continuing beneficial effects of this compound, a
further study by the University of Northumbria in the UK has confirmed what
many scientists already believe [...]

UBM Japan Pharma Events Grow Despite Air Travel Disruptions

AMSTERDAM, May 11, 2010 – Despite significant international travel restrictions due to the recent
Icelandic volcanic cloud, leading events organiser UBM International Media
and sister company UBM Japan Co. Ltd. today announced a record visitor
attendance of 14,435 at its 2010 Japanese Pharma events cluster, which took
place from 21-23 April at Tokyo's Big Sight Exhibition Center. Representing
an [...]

Culinary Competition Features Chefs from Around the World

NASHVILLE, Tennessee, May 11, 2010 – With culinary competitions among the most popular events in America, one
of the world's leading senior housing providers is hosting an intense cooking
competition among its culinary talent to crown Ultimate Chef America.

The competition is produced by Brookdale Senior Living and its Culinary
Arts Institute, a professional [...]

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting

PARIS, May 11, 2010 – The Combined Ordinary and Extraordinary Annual Meeting of Essilor
Shareholders was held today at Palais Brogniart in Paris under the
chairmanship of Xavier Fontanet, Chairman of the Board of Directors of
Essilor International.

Shareholders approved all of the resolutions submitted at the meeting,
including:

– The payment [...]

London Genetics Conference Proceedings Published in Drug Discovery Today

LONDON, May 12, 2010 – London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, is pleased to
announce that the importance of this approach is being highlighted with the
publication of its inaugural conference [1] proceedings in the May 2010 issue
of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To
Improve [...]

London Genetics Conference Proceedings Published in Drug Discovery Today

LONDON, May 12, 2010 – London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, is pleased to
announce that the importance of this approach is being highlighted with the
publication of its inaugural conference [1] proceedings in the May 2010 issue
of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To
Improve [...]

IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions

IntraLinks will Help to Meet the Pharmaceutical Industry's Objective to Move Towards Completely Paperless Clinical Trials

NEW YORK, May 12, 2010 – IntraLinks, the leading provider of critical information exchange
solutions, today announced a partnership with SAFE-BioPharma, the non-profit
association that created and manages the SAFE-BioPharma(R) digital identity
and signature standard for the pharmaceutical and healthcare industries.
IntraLinks users, [...]

Building Contract Signed With Meander Medisch Centrum

NIEUWEGEIN, The Netherlands, May 12, 2010 – On Wednesday 12 May, Meander Medisch Centrum signed a building contract
with the executing parties for the construction of Meander Medisch Centrum's
new hospital in Amersfoort, the Netherlands. Construction will start this
summer and will be realized by Heijmans Utiliteitsbouw BV, Ballast Nedam Bouw
Speciale Projecten and Burgers Ergon. The hospital [...]

Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System

Approval Includes Specific Indication for Treatment of Diabetic Patients
NATICK, Massachusetts, May 12, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced it
has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting
Coronary Stent System, the Company's third-generation drug-eluting stent
(DES) technology. This approval includes a specific indication for the
treatment of diabetic patients. The TAXUS Element Stent [...]

West Wireless Health Institute and GE Healthcare to Collaborate on Technology and Educational Initiatives

Joint Programs to Help Advance Emerging Wireless Health Industry
SAN DIEGO, May 12, 2010 – West Wireless Health Institute (WWHI) today announced a collaboration
with GE Healthcare, a global leader in health care technology, on a variety
of research, technology and educational initiatives focused on accelerating
wireless health solutions. GE Healthcare has demonstrated innovative
leadership in the emerging wireless [...]

INTUNIV(TM) – Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.

DUBLIN and PHILADELPHIA, May 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiary Shire LLC has filed
a lawsuit in the U.S. District Court for the District of Delaware against
Actavis Elizabeth LLC and Actavis Inc. (collectively "Actavis") for the
infringement of U.S. Patent Nos. 5,854,290 (the '290 patent), [...]

ZS Associates Wins 2010 Lilly Global Sustained Supplier Award

EVANSTON, Illinois, May 13, 2010 – Global consulting firm ZS Associates today announced that it has been
awarded the 2010 Lilly Global Sustained Supplier Award from leading
biopharmaceutical corporation Eli Lilly and Company.

The award recognizes ZS Associates' contribution to helping the
Indianapolis-based pharmaceutical company make a measurable impact on
Lilly's corporate priorities by delivering [...]

Sequent Medical Announces Closing of US$15.6 Million Venture Capital Financing

ALISO VIEJO, California, May 13, 2010 – Sequent Medical, Inc. announced today that it has closed a US$15.6
million Series B venture capital financing. The financing was led by Domain
Associates, joined by existing investors Versant Ventures and US Venture
Partners. Nimesh Shah of Domain will join Sequent's Board of Directors.

"We are privileged [...]